The right balance?
The release of the Schedule Y amendment on January 20, 2005 and the CDSCO notice dated October 5, 2016 about the ‘SUGAM’ portal…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
What more for clinical research in India?
Dr Chirag Trivedi, President, Indian Society for Clinical Research (ISCR),emphasises on the importance of clinical trials in drug…
Quality with a supersized Q
Naz Haji, SVP and Managing Director, QuintilesIMS India, elaborates on the need to improve awareness amongst the Indian public…
Building on strengths
Boehringer Ingelheim is undergoing a comprehensive transformation to derive more growth and value through strategic realignment of…
Pipeline drug offers promise in treatment of platinum-resistant ovarian cancer: GlobalData
ImmunoGen announced that the first patient was dosed in its pivotal Phase III study that investigates mirvetuximab soravtansine as…
Bladder cancer market size to more than triple to over $1.1 billion by 2025
The growth will be driven by the increased incorporation of immunotherapies into treatment algorithms, the launch of new…
Strict or stringent national regulatory authority for procurement of anti-tuberculosis medicines?
John F Loeber, Chief Procurement Officer, UN Stabilisation Mission in Haiti (MINUSTAH) Port-au-Prince, Haiti, in this article…
Fatty liver disease prevalence leads pharma companies look to first in-class drugs
According to GBI Research, fatty liver disease has increased rapidly in the past several decades and is now estimated at 20-45 per…
Global cancer supportive care therapeutics market to see negligible growth to $12.4 billion by 2022
According to GBI Research, negligible growth can be attributed to the patent expiries of some of the therapy area’s most…
Partnerships with healthcare organisations, government aid disaster management
Shripad Desai, MD and Country Director , Americares India Foundation, Mumbai, explains how synergy between NGOs, pharmaceutical…